Search

Your search keyword '"Rosso C."' showing total 113 results

Search Constraints

Start Over You searched for: Author "Rosso C." Remove constraint Author: "Rosso C." Publisher elsevier bv Remove constraint Publisher: elsevier bv
113 results on '"Rosso C."'

Search Results

1. A translational roadmap for transcranial magnetic and direct current stimulation in stroke rehabilitation: Consensus-based core recommendations from the Third Stroke Recovery and Rehabilitation Roundtable

2. Magnetic Resonance-based fibrosis markers in patients with Non-Alcoholic Fatty Liver Disease: Exploratory data from the Turin cohort

3. A nutrigenetic precision approach for the management of NAFLD

6. T.07.3 PROGNOSTIC VALUE OF LIVER STIFFNESS AND FIB-4 SCORE IN INDIVIDUALS WITH CIRRHOSIS DUE TO NON-ALCOHOLIC FATTY LIVER DISEASE WITHOUT PREVIOUS LIVER DECOMPENSATION

7. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response

8. Interferon gamma-induced protein 10 levels are associated with insulin resistant components in subjects with non-alcoholic fatty liver disease

9. Social jetlag and mediterranean diet adherence are associated to liver fibrosis in patients with non-alcoholic fatty liver disease

10. Echocardiography-based markers of subclinical cardiac dysfunction in individuals with Non-Alcoholic Fatty Liver Disease and preserved ejection fraction: Interim data from a prospective study

11. Prognostic value of simple non-invasive tests for the risk stratification of hcc development in patients with cirrhosis due to non-alcoholic fatty liver disease

14. The role of histidine-rich glycoprotein in non alcoholic steatohepatitis-related experimental liver carcinogenesis

15. MiRNome profiling of circulating extracellular vesicles in patients with chronic hepatitis delta treated with pegylated interferon alpha

16. Liver cancer-specific isoform of serine protease inhibitor Kazal for the detection of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

17. OC-07A machine learning approach for the classification of NASH vs NAFL in diabetic and non-diabetic subjects reveals a strong association between liver inflammation and adipose tissue dysfunction

19. Increased serum ferritin levels predict long-term mortality in patients with NAFLD

21. Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3)

22. Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease

27. Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease

30. Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease. An international study in non-cirrhotic, biopsy-proven patients

32. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

35. Bile acid composition modulate insulin resistance in non-diabetic patients with NAFLD

36. In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease

40. Increased hepatic glucose production and insulin resistance are associated to increased plasma concentrations of glucogenic amino acids in subjects with NAFLD

46. Increased hepatic glucose production and insulin resistance in subjects with non-alcoholic fatty liver disease is associated to increased plasma concentrations of glucogenic amino acids

48. Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage

49. Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease

50. Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease

Catalog

Books, media, physical & digital resources